BioLargo Spotlight: Advanced Oxidation System (AOS) Versus Waterborne Viruses

Re-posted from biolargo.blogspot.com
 
Hello, my name is Dr. Laura Patterson-Fortin, lead for BioLargo Water’s disinfection R&D team in Edmonton. My team has previously reported many exciting results using the AOS for water disinfection. In today’s blot post, I hope to inform our shareholders and followers of some really positive recent results we’ve achieved in virus disinfection, and to share a little bit on how and why we choose to use viral surrogates for our studies, namely Bacteriophages T4 and MS2. 
First, the results! You may have read in previous disclosures that our AOS consistently eliminates about 4 logs (or 99.99%) of Bacteriophage MS2 from water, which is more than a sufficient level of virus disinfection for most target water treatment applications. We’re proud to say that because of physical improvements to our AOS, we’ve increased our MS2 disinfection performance rate to 6 logs (or 99.9999%), which is effectively a 100x increase in performance. This is terrific news, because once we prove this increase in virus disinfection performance translates at industrial scale, we believe it will represent a significant competitive advantage over other water treatment technologies due to the AOS' greater kill rates and lower operational costs compared to other water disinfection technologies in many applications.
 
Source: The Institute for Molecular Virology
 
 
 
 
 
 
 
 
 
 
 
 
 
Why do we (and others who do water disinfection development work) use Bacteriophage MS2 to test our AOS’ virus disinfection capabilities? A fine question, reader. The reason we test our technology’s ability to kill viruses using a surrogate like MS2 is that it’s a safe, cost-effective, and relevant way to assess virus disinfection performance compared to directly testing with highly dangerous human pathogens like hepatitis A, Norwalk virus, or Enteroviruses. Typically, only very special (and very expensive) labs with strict certifications work with human viruses, and even if that weren’t the case, it’s very time-consuming and expensive to work with human viruses. This is why the scientific community generally accepts virus disinfection results with Bacteriophage MS2 and other surrogates, with the understanding that once a technology goes commercial it will be tested and certified to work against actual human viruses.
This is why we are very excited about our recent results with MS2 disinfection – they show that our AOS is a powerful tool for disinfecting water containing viruses, and we’re anxious to see it commercialized and treating water around the world.
If you found this post interesting, or you would like to learn more about virus disinfection, don’t hesitate to engage us on social media at BioLargo Water’s Twitter account @BioLargoWater and BioLargo’s Twitter @BioLargo, or at our Facebook page.

What is a BioLargo Spotlight?
It’s an exciting time at BioLargo. We’re moving fast, and it can be difficult to keep our stockholders and the investing public informed of our progress. In light of this, we will be posting a series of short articles titled “BioLargo Spotlight”, highlighting certain business activities and other important information in between our required SEC filings. Of course, these do not replace our public filings, which contain more complete information than can be delivered in this forum, and thus we urge you to carefully read and rely on those filings for definitive information, and to review our risk factors and caution regarding forward-looking statements. We are optimistic about our business as we work hard to continue to grow and ultimately generate profits for our stockholders.   
Legal Disclaimer
Our attorneys remind us that while we believe these developments are important and that these small victories could add up and lead to big victories, at this stage they do not rise to the level of an official material disclosure. As the size and magnitude of these developments become material, we will naturally report that information in an 8-K and our regular SEC filings.
 

Comments

Post a Comment

Popular posts from this blog

BioLargo Spotlight: Introducing the Spiral AOS

Image
Originally posted on December 14, 2018 In our previous blog posts that detailed the science behind BioLargo Water’s Advanced Oxidation System (AOS), we explained that the AOS treats water by generating reactive iodine molecules at its electrodes. The iodine molecules generated inside the AOS decontaminate and disinfect water in two fundamental ways: 1) by the oxidation of proteins inside bacteria, viruses, or protozoa and 2) by altering the structure of chemical pollutants, often breaking them down entirely. Explaining the mechanism of how the AOS works, we showcased just how effective the AOS is at reducing electrical and consumable costs while treating water. In this blog, we will elaborate upon recent radical design changes BioLargo Water has made to the AOS as part of our effort to continuously improve our technology, and we will illuminate how and why these decisions will result in a more effective and economical product for end-users. Fig 1: Diagram of water flow
Read more

BioLargo Spotlight: NSERC Grant Awarded to Evaluate AOS Water Chemistry

Image
Originally posted Tuesday, October 9, 2018 If you follow BioLargo Water and its Advanced Oxidation System, you may sometimes wonder how exactly it functions – ie how does it actually treat water? You have probably seen our short descriptions of its function: that it generates highly reactive iodine molecules at its electrodes, resulting in disinfection and decontamination, but the truth is A) this is an oversimplification and B) you may not be entirely clear on what this means! To expand on this simplified explanation: in the AOS there are two modes of actions by which it treats water. One is the oxidation – the chemical action of removing electrons - of proteins inside bacteria passing through the AOS, resulting in inactivation or killing of those bacteria. The second mode of action is the breaking down of pollutants by oxidation, that is to say the structural or chemical alteration of chemical pollutants by the process of oxidation. A peak at an AOS Spiral Reactor
Read more

BioLargo Spotlight: Pharmaceuticals in Water

Image
Originally posted on September 20, 2018 Diseases are treated and cured with man-made chemicals every day – it’s a fact of life. However, scientists and public officials have long be concerned with the question: what happens when those chemicals (pharmaceuticals) come in contact with a healthy person? As is often the case in science, the answer is: well …. It depends! When a human or animal consumes pharmaceutical products (PPs), what happens to them? These substances are excreted, disposed from the households through sewers and released into the aquatic environment. PP s  are an important group of potential  endocrine-disrupting compounds (EDCs) which have recently attracted much attention of the international scientific community. PP s  such as analgesics, antibiotics, antiseptics, hormones and antidepressants were detected in influents of wastewaters treatment plants, in surface water, in ground water and even in drinking water resources across the world. Their occurrence an
Read more